Compliance updated on Jun 19, 2026 Screened by AAOIFI-Certified Shariah Advisor & Auditor

Financial data updated nightly

Avicanna Inc

AVCN.TO ✓ COMPLIANT ☆ Track — members

TSX · Healthcare · Biotechnology & Medical Research ·

Canada Micro Cap Analyst: N/A

Last Close

$0.10

▲ +3.85%

Market Cap $13.02M · Vol 47.03K

Key Metrics

P/E Ratio

N/A

FWD: N/A

Market Cap

$13.02M

Micro Cap

Div Yield

N/A

EPS Growth

N/A

YoY

RSI (14)

50.00

Momentum

Beta

0.29

vs Market

52W High

$0.21

54.07% below

52W Low

$0.07

45.17% above

Volume

47.03K

Avg 93.17K

P/B

9.34

Price-to-book

ROE

N/A

Return on equity

Free Float

76.28%

Public shares

Shariah Compliance8 STANDARDS

✓ Yes, Avicanna Inc (AVCN.TO) stock is Shariah compliant

AAOIFI—
Dow Jones Islamic (DJIM)—
FTSE Shariah—
MSCI Islamic—
S&P Shariah—
Al Rajhi—
Alinma—
Albilad—

Unlock the full Shariah report

See the verdict under each standard, the exact screening ratios, purification and zakat per share. AAOIFI-certified methodology trusted by global Islamic funds.

Which standards does AVCN.TO pass?

The full report shows the verdict under each of the 8 major Shariah standards, with the business-activity and financial-ratio screens behind every one.

Do I need to purify my investment?

Members see the purification amount per share, updated every financial period under the AAOIFI methodology.

Can I calculate zakat for my shares?

Members get zakat per share and a built-in calculator for their exact holding.

Historical Returns

+0.00%

+8.00%

+0.00%

-20.59%

YTD

-40.00%

-50.00%

-46.39%

-87.50%

Financials & Valuation

TTM · Annual

Total Revenue	$18.57M
Net Income	$-2,010,493.00
Revenue Growth (YoY)	+5.63%
Gross Margin	50.99%
Operating Margin	-10.07%
Net Profit Margin	-10.83%
ROE	N/A
ROA · ROIC	-13.57% · N/A

P/E Ratio	N/A
Forward P/E (FY1)	N/A
PEG Ratio	N/A
P/S	1.01
P/B	9.34
P/FCF	N/A
EPS Growth	N/A
Outstanding Shares	134.38M

Technical Indicators

50-Day SMA	$0.09
200-Day SMA	$0.13
RSI (14)	50.00
Beta	0.29
52-Week High	$0.21
52-Week Low	$0.07

Volume Today	47.03K
Avg Daily Volume (30D)	93.17K
Relative Volume	0.50x
Volatility (10D)	54.21
Volatility (30D)	68.12
Free Float	76.28%

Analyst Consensus

N/A

Current Price $0.10

Mean Target N/A

52W Low$0.07 52W High$0.21

Current

Target

$0.07 $0.21

Current Analyst target

· 0 analysts

Identifiers

ExchangeTSX

FIGIBBG00GTTT5T5

ISINCA05368K1003

CountryCanada

Sub-IndustryBiotechnology & Medical Research (NEC)

Earnings DateN/A

TypeStocks

Instrument TypeORD Ordinary Share

Similar Halal Stocks

LONN.S Lonza Group AG -1.78% RVMD Revolution Medicines Inc +0.85% ONC BeOne Medicines AG -2.40% 068270.KS Celltrion Inc -0.50% ABVX Abivax SA -2.05%

Company Profile

Avicanna Inc. is a commercial-stage international biopharmaceutical company. It focuses on the advancement and commercialization of cannabinoid-based products and formulations for the global medical and pharmaceutical market segments. Its products and services are grouped into four main categories, such as medical cannabis products; MyMedi.ca medical cannabis platform; pharmaceutical pipeline; and active pharmaceutical ingredients. The formulary of proprietary medical cannabis products is marketed under the RHO Phyto brand and offers a range of scientifically driven formulations in a variety of products, including oral, sublingual, topical, and transdermal deliveries with varying ratios of cannabinoids. MyMedi.ca offers a diverse portfolio of products and bilingual pharmacist-led patient support programs. It has developed a pipeline of proprietary, indication-specific cannabinoid-based candidates that are in various stages of clinical development. Trunerox is its oral formulation.